GLICLAZID Mepha retard depotabs 60 mg 30 pce

7680655710016 CH-65571 A10BB09 07.06.2.

Reimbursement limitations:

DIAMICRON

Pris en charge lorsque la metformine ne permet pas un contrôle suffisant de la glycémie.

GLICLAZID Mepha retard depotabs 60 mg 30 pce
GLICLAZID Mepha retard depotabs 60 mg 30 pce
GLICLAZID Mepha retard depotabs 60 mg 30 pce
1 / 3
google

Details

Product number
6557101
CPT
-
Packaging group
30
Unit
Tablette(n)
Composition
gliclazidum 60 mg, excipiens pro compresso obducto.

Articles (1)

Gliclazid-Mepha 60 retard, Depotabs
Tabletten
30
View

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
(N/A)
60.0 MG Substance Wirkstoff (Principe actif)

Reimbursement information

Public price
CHF 17.75
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/05/2015

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
65571
Drug name
Gliclazid-Mepha 60 retard, Depotabs
Galenic form
RETT
ATC Code
A10BB09
Authorization status
Z
Dispensation category
B
First authorization
26/02/2015
Authorization expiration date
31/12/9999
IT number
07.06.2.
Domain
Human medicine
Field of application
Orale blutzuckersenkende Mittel

Packaging details

Description (FR)
GLICLAZID Mepha retard depotabs 60 mg 30 pce
Description (DE)
GLICLAZID Mepha retard Depotabs 60 mg 30 Stk
Market launch
26/02/2015
Narcotic (BTM)
No

Original drug

Diamicron MR, comprimés à libération modifiée
CHF 18.20
View original

Other packaging sizes

GLICLAZID Mepha retard depotabs 60 mg 90 pce
90 TABL
View